MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

Filter Criteria [Hide filter]
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
Too much news? Try filtering with NewsWatch. Alternatively, try our Desktop News Alert.

The following articles are from the past month only. Click here for older news.
 
Next
28/05/25 13:31 Angle PLC (AGL) Angle shares fall on weak 2025 outlook despite narrower annual loss ALN
28/05/25 11:06 Angle PLC (AGL) AIM WINNERS & LOSERS: Frontier Developments revenue to beat consensus ALN
21/03/25 14:25 Angle PLC (AGL) Angle hails successful completion of Eisai contract; approval by Astra ALN
29/01/25 16:26 Angle PLC (AGL) Angle reports breakthrough in dual cancer DNA analysis ALN
23/01/25 14:22 Angle PLC (AGL) Angle fails to win market confidence despite narrowing loss in 2024 ALN
15/11/24 14:33 Angle PLC (AGL) Angle stock surges as firm showcases new assay products ALN
11/11/24 12:07 Angle PLC (AGL) Angle notes use of Parsortix system in treatment resistance study ALN
19/09/24 14:44 Angle PLC (AGL) IN BRIEF: Angle celebrates agreement with Recursion Pharmaceuticals ALN
23/08/24 11:43 Angle PLC (AGL) IN BRIEF: Angle hails publication of research data in science journal ALN
21/06/24 10:52 Angle PLC (AGL) IN BRIEF: Angle says open offer raises proceeds of £500,000 ALN
03/05/24 12:17 Angle PLC (AGL) CORRECT: Angle shares up on assay development deal with AstraZeneca ALN
03/05/24 11:50 Angle PLC (AGL) Angle shares up on assay development deal with AstraZenaca ALN
22/04/24 16:52 Angle PLC (AGL) IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide ALN
22/01/24 18:03 Angle PLC (AGL) IN BRIEF: Angle highlights supportive data for DNA analysis tool ALN
04/01/24 12:19 Angle PLC (AGL) Angle shares soar following ‘breakthrough’ cancer diagnostics results ALN
02/01/24 08:51 Angle PLC (AGL) IN BRIEF: Angle teams with Japan’s Eisai in breast cancer drug trial ALN
05/12/23 11:50 Angle PLC (AGL) IN BRIEF: Angle launches diagnostic kit at cancer symposium ALN
09/11/23 14:29 Angle PLC (AGL) Angle says build up of revenue slower than hoped; launches test ALN
03/10/23 13:02 Angle PLC (AGL) Angle hails study which shows Parsortix outperforming lab standard ALN
07/09/23 14:41 Angle PLC (AGL) EARNINGS UPDATES: Sylvania beats production goal, Angle revenue surges ALN
04/09/23 14:21 Angle PLC (AGL) Angle launches tumour cell assay to ‘unlock’ customised cancer care ALN
05/06/23 12:26 Angle PLC (AGL) IN BRIEF: Angle hires Swansiger as new COO and Miller as new CSO ALN
25/05/23 14:34 Angle PLC (AGL) IN BRIEF: Angle customer to use biopsy products in clinical trial ALN
22/05/23 13:53 Angle PLC (AGL) IN BRIEF: Angle promotes Jan Groen to chair, replacing Garth Selvey ALN
21/04/23 10:43 Angle PLC (AGL) Angle loss widens in 2022 despite being ‘breakthrough’ year ALN
10/02/23 06:04 (AGL) Director Deals - (AGL) BFN
10/02/23 06:04 (AGL) Director Deals - (AGL) BFN
10/02/23 06:04 (AGL) Director Deals - (AGL) BFN
10/02/23 06:04 (AGL) Director Deals - (AGL) BFN
05/01/23 10:25 Angle PLC (AGL) Angle expects 2023 growth to fall short of market expectations ALN
24/10/22 14:35 Angle PLC (AGL) IN BRIEF: Angle presents positive study results for Parasortix ALN
12/09/22 14:31 Angle PLC (AGL) Angle notes Parsortix success in pelvic mass pilot study ALN
19/07/22 15:05 (AGL) Director Deals - (AGL) BFN
19/07/22 15:05 (AGL) Director Deals - (AGL) BFN
15/07/22 14:45 Angle PLC (AGL) IN BRIEF: Angle raises £20 million to progress Parsortix ALN
22/06/22 10:01 Angle PLC (AGL) Angle wins cancer monitoring contract for Parasortix system ALN
14/06/22 20:13 Angle PLC (AGL) IN BRIEF: Angle's Parsortix performs well on prostate cancer patients ALN
30/05/22 15:21 Angle PLC (AGL) IN BRIEF: Angle partners with US urology group for Parasortix study ALN
25/05/22 21:19 Angle PLC (AGL) IN BRIEF: Angle shares rocket as Parasortix receives US FDA approval ALN
20/05/22 09:48 Angle PLC (AGL) IN BRIEF: Cancer study using Angle's Parasortix secures funding ALN
29/03/22 20:29 Angle PLC (AGL) IN BRIEF: Angle's Parsortix can help with cancer treatment options ALN
30/08/21 06:10 (AGL) Director Deals - (AGL) BFN
15/07/21 06:09 (AGL) Director Deals - (AGL) BFN
15/07/21 06:09 (AGL) Director Deals - (AGL) BFN
15/07/21 06:09 (AGL) Director Deals - (AGL) BFN
01/06/21 09:24 Angle PLC (AGL) Angle hails Washington University research showing utility of Parsortix system BFN
11/05/21 09:44 Angle PLC (AGL) Angle's parsortix system identifies therapeutic targets in breast cancer study BFN
29/04/21 09:33 Angle PLC (AGL) Angle losses widen in H1 on increased investment spend BFN
26/04/21 09:20 Angle PLC (AGL) Angle completes patient enrolment for ovarian cancer clinical verification study BFN
16/04/21 07:54 Angle PLC (AGL) Angle wins maiden pharma services contract worth $1.2m BFN
Next